HIDROVIAS (HBSA3) Main Indicators
Basic Data - HBSA3
| Company | HIDROVIAS |
| Corporate Name | HIDROVIAS DO BRASIL S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Operador de logística hidroviária para clientes de commodities agrícolas. minerais. combustíveis e derivados e carga. integrando o transporte por barcaças com operação de terminais de origem e destino |
| Share | HBSA3 |
| Quote Date | 04/01/2025 |
| Share Type | ON |
| Last Closing | R$ 2.29 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 7.28 M |
| Last Statement | DFP - 12/31/2024 |
| Sector | Bens Industriais |
| Subsector | Transporte |
| Segment | Transporte Hidroviário |
| Participation Indexes | AGFS, GPTW, IBRA, IGC, IGCT, IGNM, ITAG, SMLL |
| Updated 04/02/2025 | |
Relative Prices - HBSA3
| Price/Earnings | -2.80 |
| Price/SBV | 1.84 |
| Price/Net Sales | 1.29 |
| Price/CFO | 14.29 |
| Price/FCF | -9.18 |
| Price/Total Assets | 0.24 |
| Price/EBIT | -4.71 |
| Price/Working Capital | -2.55 |
| Price/NCAV | -0.25 |
| EV/EBIT | -15.89 |
| EV/EBITDA | 119.46 |
| EV/Net Sales | 4.34 |
| EV/CFO | 48.18 |
| EV/FCF | -30.95 |
| EV/Total Assets | 0.82 |
| Company Market Cap | R$ 1.74 B |
| Enterprise Value | R$ 5.87 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 2.29 |
| Share Price Date | 04/01/2025 |
| Dividend Yield | 0.00% |
| Updated 04/02/2025 | |
Income Statement - HBSA3
| Net Revenue | R$ 1.35 B |
| Gross Result | R$ 6.41 M |
| EBIT | - R$ 369.48 M |
| Depreciation and Amortization | - R$ 418.63 M |
| EBITDA | R$ 49.16 M |
| Net Profit | - R$ 621.70 M |
| Net Profit/Share | - R$ 0.82 |
| Updated 02/24/2025 | |
| Net Revenue | R$ 60.79 M |
| Gross Result | - R$ 278.85 M |
| EBIT | - R$ 427.40 M |
| Depreciation and Amortization | - R$ 112.98 M |
| EBITDA | - R$ 314.42 M |
| Net Profit | - R$ 446.00 M |
| Profit/Share | - R$ 0.59 |
| Updated 02/24/2025 | |
Price and Volume Behavior - HBSA3
| Lowest Price 52 weeks | R$ 1.77 |
| Highest Price 52 weeks | R$ 4.54 |
| Variation 2025 | -16.12% |
| Variation 1 year | -46.50% |
| Variation 2 years(total) | 6.51% |
| Variation 2 years(yearly) | 3.20% |
| Variation 3 years(total) | -34.76% |
| Variation 3 years(yearly) | -13.26% |
| Variation 4 years(total) | -62.02% |
| Variation 4 years(yearly) | -21.49% |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 8.72 M |
| Updated 04/02/2025 | |
Returns and Margins - HBSA3
| Return on Initial Tangible Capital | -5.11% |
| Return on Initial Invested Capital | -4.86% |
| Pre-Tax Return on Initial Tangible Capital | -7.75% |
| Pre-Tax Return on Initial Invested Capital | -7.37% |
| Return on Initial Shareholder´s Equity | -44.94% |
| Return on Initial Asset | -9.95% |
| Gross Margin | 0.47% |
| Net Margin | -45.97% |
| EBIT Margin | -27.32% |
| EBITDA Margin | 3.63% |
| Initial Asset Turnover | 0.22 |
| Financial Leverage | 7.56 |
| Liabilities/Net Worth | 6.56 |
| Net Debt/EBITDA | 84.04 |
| Updated 02/24/2025 | |
Balance Sheet - HBSA3
| Cash and Cash Equivalents | R$ 988.45 M |
| Total Assets | R$ 7.17 B |
| Short-Term Debt | R$ 1.40 B |
| Long-Term Debt | R$ 3.72 B |
| Gross Debt | R$ 5.12 B |
| Net Debt | R$ 4.13 B |
| Shareholder´s Equity | R$ 948.08 M |
| Share Book Value | R$ 1.25 |
| Common Shares | 760,383,000 |
| Preferred Shares | 0 |
| Total | 760,383,000 |
| Common Shares in Treasury | 0 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 0 |
| Common Shares (Except Treasury) | 760,383,000 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 760,383,000 |
| Updated 02/24/2025 | |
Cash Flow - HBSA3
| Operating Cash Flow | R$ 121.88 M |
| Cash Flow from Investments | - R$ 207.80 M |
| Financing Cash Flow | R$ 355.18 M |
| Increase (Reduction) in Cash and Equivalents | R$ 324.53 M |
| Updated 02/24/2025 | |
| Operating Cash Flow | - R$ 60.14 M |
| Cash Flow from Investments | - R$ 142.68 M |
| Financing Cash Flow | R$ 471.20 M |
| Increase (Reduction) in Cash and Equivalents | R$ 301.46 M |
| Updated 02/24/2025 | |
Experimental - HBSA3
| CAPEX 3 months | - R$ 154.73 M |
| Free Cash Flow 3 months | - R$ 214.87 M |
| CAPEX 12 months | - R$ 311.65 M |
| Free Cash Flow 12 months | - R$ 189.77 M |
| Updated 02/24/2025 | |